Abiopharma

Blue Moon Reports Assay of 0.180% Germanium, 0.0273% Gallium and 1.96% Copper from Bulk Sample at Apex and Provides Apex Project Update

Bullish receives Gibraltar Financial Services Commission approval to offer trading in tokenized securities

Change - Announcement of Cessation: CEASATION OF NON EXECUTIVE DIRECTOR

Net Asset Value(s)

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Disclosure of Interest by CEO - Liaw Liang Huat Joshua

Investor conference presentation

Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s): Change in Interest of Substantial Shareholder

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Notification Form for Director in respect of Interests in Securities

Net Asset Value(s)

UTHR: United Therapeutics Corporation Announces FDA Approval of theLungFX™ Device for Centralized Ex Vivo Lung Perfusion